Aliskiren reduces vascular pathology in diabetic retinopathy and oxygen-induced retinopathy in the transgenic (mRen-2)27 rat

Jennifer Wilkinson-Berka, Genevieve Tan, Katrina Binger, Lainie Sutton, Kylie McMaster, Devy Deliyanti, Gayathri Perera, Duncan Campbell, Antonia Miller

Research output: Contribution to journalArticleResearchpeer-review

24 Citations (Scopus)

Abstract

We examined whether the renin inhibitor, aliskiren, provides similar or greater protection than ACE inhibition from non-proliferative diabetic retinopathy and from the proliferative neoangiogenesis of oxygen-induced retinopathy.
Original languageEnglish
Pages (from-to)2724 - 2735
Number of pages12
JournalDiabetologia
Volume54
Issue number10
DOIs
Publication statusPublished - 2011

Cite this